-Member Login


Job Postings

Let's Stay Connected

Find us on the popular social networks

Facebook Twitter LinkedIn Flicker

U.S. House of Representatives Approves 21st Century Cures; Bill Heads to Senate

Go back To Policy Updates


The House on November 30 approved the 21st Century Cures Act , 392-26, amended by a Manager’s Amendment submitted by House Energy and Commerce Chair Fred Upton (R-Mich.). While the Manager’s Amendment modifies slightly the allocation of funding in the NIH Innovation Account on an annual basis, it maintains the overall level of funding in the Account at a total of $4.796 billion between FYs 2017 and 2026. For the Precision Medicine Initiative, the Amendment provides $1.455 billion between FYs 2017 and 2026; for BRAIN, $1.511 billion between FYs 2017 and 2026; for cancer research, $1.8 billion between FYs 2017 and 2023; and for clinical research to advance regenerative medicine using adult stem cells, the Amendment provides $30 million between FYs 2017 and 2020.

Committee materials, bill text, list of supporting organizations, and the Manager’s Amendment and other materials are available at the following links:

Last updated: December 1, 2016 

Hot Links 

Advertise in Explore Pharmacology 2017 

2017 Award Nominations Side 


What is Pharmacology? Video 

PharmTalk Blog